Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.
Tumor necrosis factor-alpha (TNF) has been unequivocally validated as a therapeutic target in a number of immune-mediated inflammatory disorders (IMIDs). There is now increasing choice of biologic agents within the class all of which successfully neutralize sTNF. But approaches to TNF inhibition dif...
| Hlavní autor: | |
|---|---|
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
2010
|